CSIMarket
 
Gala Pharmaceutical Inc.  (GLAG)
Other Ticker:  
 
 

Gala Pharmaceutical Growth Comparisons

Select each growth Category to receive further Information



GLAG Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) - 0.85 % 1.55 % 3.55 %
Q / Q Revenue Growth (Q2 MRQ) - -0.52 % 2.84 % 4.37 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) - 7.09 % 6.58 % %
Seq. Revenue Growth (for 12 months ending Q2 TTM) - 0.2 % 0.06 % 0.84 %
Revenue 5 Year Average Growth - 4.77 % 4.38 % 9.12 %


GLAG's Growth Comparisons in II. Quarter 2019




Gala Pharmaceutical reported top-line of $ 0 millions in the second quarter 2019, compare to $ 0 millions in the same quarter a year ago. Revenues in the Apparel, Footwear & Accessories industry grew by 0.85%, while the top-line in the Consumer Discretionary sector increased by 1.55%, and overall market improved by 3.55% from the second quarter 2018.

Sequentially company's Revenue were unchanged from the first quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the second quarter 2019 earnings reports, average yearly sales growth is 9.12%.


Growth Rates of GLAG's Income in the second quarter 2019


GLAG Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 0.39 % -8.83 % -3.92 %
Seq. Operating Income Change (Q2 MRQ) - 3.63 % 43.94 % 31.33 %
Y / Y Operating Income Growth (Q2 TTM) - 24.02 % -7.81 % -12.37 %
Seq. Operating Income Growth (Q2 TTM) - 0.09 % -2.93 % -1.08 %
Operating Income 5 Year Avg. Change - 0.26 % -16.53 % 11.3 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -12.1 % -16.39 % -2.67 %
Seq. Income from Cont. Ops. Change (Q2 MRQ) - -7.13 % 2.78 % 2.36 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 115.78 % 53.6 % 15.1 %
Seq. Income from Cont. Ops. Change (Q2 TTM) - -2.54 % -4.73 % -0.56 %
Income from Cont. Ops. 5 Year Avg. Change - -1.95 % -8.52 % 8.56 %

GLAG Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -14.4 % 20.51 % -1.56 %
Q / Q Net Income Growth (Q2 MRQ) - -9.54 % 41.99 % -1.22 %
Y / Y Net Income Change (Q2 TTM) - 125.31 % 108.63 % 15.49 %
Seq. Net Income Change (Q2 TTM) - -3.02 % 3.99 % -0.81 %
Net Income 5 Year Avg. Growth - -1.25 % -7.96 % 8.14 %

GLAG's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -25.7 % -16.39 % -2.67 %
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - 1155.04 % 2.78 % 2.36 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - 93.84 % - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - 0.45 % -4.99 % 1.19 %
EPS from Cont. Ops. 5 Year Avg. Growth - -7.8 % -8.52 % 8.56 %



GLAG EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -27.64 % 20.51 % -1.56 %
Q / Q EPS Net Growth (Q2 MRQ) - 1122.5 % 41.99 % -1.22 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - 84.75 % 31.12 % 64.21 %
Seq. EPS Net Change (for 12 months ending Q2 TTM) - 0.42 % -0.37 % 0.77 %
EPS Net 5 Year Avg. Change - -1.25 % -7.96 % 8.14 %



Gala Pharmaceutical reported bottom-line of $ -0.02 in the second quarter, compare to $ -0.01 in the same quarter a year ago. Apparel, Footwear & Accessories industry fell by -27.64%, while Consumer Discretionary sector increased by 20.51%, and overall market declined by -1.56%.

Sequentially company's EPS were unchanged from the first quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the second quarter 2019 financial results, average yearly income per share growth is 8.14%.

GLAG Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - -25.05 % -2.91 % -5.2 %
Seq. Free Cash Flow Change (Q2 MRQ) - - 918 % 151.93 %
Y / Y Free Cash Flow Change (Q2 TTM) - -17.41 % -6.55 % -2.89 %
Seq. Free Cash Flow Change (Q2 TTM) - -7.74 % -2.74 % -0.64 %
Free Cash Flow 5 Year Avg. Change - 6.01 % -7.83 % 32.47 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - -58.05 % -56.71 % -
Seq. Net Cash Flow Change (Q2 MRQ) - 167.3 % - -
Y / Y Net Cash Flow Change (Q2 TTM) - - - -
Seq. Net Cash Flow Change (Q2 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - - -39.32 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - 5.13 % -20.76 % 8.09 %
Seq. Capital Expenditures Change (Q2 MRQ) 3841.85 % 53.59 % -8.96 % 7.69 %
Y / Y Capital Expenditures Change (Q2 TTM) 158.65 % 2.46 % -10.15 % 5.78 %
Seq. Capital Expenditures Change (Q2 TTM) 3941.85 % 1.33 % -4.97 % 0.75 %
Capital Expenditures 5 Year Avg. Change -